Showing results (1-10 of 106) with videos related to
Sort By:
Pageof 11
Biochemical Pharmacology|August 10, 2015
On Becoming a Pharmacologist: Channeling David TriggleDavid Rampe, Murali GopalakrishnanBiochemical Pharmacology|August 21, 2007
Allosteric modulation of nicotinic acetylcholine receptorsDaniel Bertrand, Murali GopalakrishnanCurrent Protocols in Pharmacology|September 30, 2011
Electrophysiological analysis of ATP-sensitive potassium channels in mammalian cells and Xenopus oocytesChar-Chang Shieh, Murali GopalakrishnanExpert Opinion on Therapeutic Targets|October 8, 2004
Potassium channel subtypes as molecular targets for overactive bladder and other urological disordersMurali Gopalakrishnan, Char-Chang ShiehBritish Journal of Pharmacology|January 6, 2010
Positive allosteric modulation of alpha7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neuronsMin Hu, Murali Gopalakrishnan, Jinhe LiJournal of Pharmacological and Toxicological Methods|March 30, 2013
A history of the role of the hERG channel in cardiac risk assessmentDavid Rampe, Arthur M BrownAssay and Drug Development Technologies|August 23, 2014
L-type Ca2+ channel responses to bay k 8644 in stem cell-derived cardiomyocytes are unusually dependent on holding potential and charge carrierJunzhi Ji, Jiesheng Kang, David RampeBrain Research|March 10, 2010
Alpha7 nAChR-mediated activation of MAP kinase pathways in PC12 cellsEarl J Gubbins, Murali Gopalakrishnan, Jinhe LiRecent Patents on CNS Drug Discovery|January 29, 2008
Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptorRamin Faghih, Gregory A Gfesser, Murali GopalakrishnanExpert Opinion on Drug Discovery|March 20, 2013
The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditionsMichael W Decker, Murali Gopalakrishnan, Michael D MeyerPageof 11